Firstly, interstitial lung disease associated with anti-MDA5 antibody-positive DM requires potent immunosuppressive therapy, highlighting the importance of vigilance for various side effects, including opportunistic fungal infections. The gene discussed is IFIH1; the disease is dermatomyositis.